Ondansetron HCL 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQKBW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,707
Award facts
- Contract value 100% obligated
- $17,706.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,706.56 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets in quantities of 30 units. This firm fixed price delivery order, issued on September 26, 2025, represents a non-competitive set-aside award and is scheduled for completion by September 29, 2025. The product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a widely-used anti-nausea medication critical for military and veteran healthcare applications, particularly in surgical and chemotherapy settings.
This delivery order functions as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to fulfill federal medical procurement requirements across a diverse portfolio of medications and medical supplies for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's substantial contract history with DLA reflects its critical role in supporting the pharmaceutical supply chain for military medicine globally.
Quick answers
Who was awarded contract SPE2DB25FQKBW?
SPE2DB25FQKBW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FQKBW worth?
The government has obligated $17,707 on SPE2DB25FQKBW.
Is contract SPE2DB25FQKBW an order under another contract?
Yes. SPE2DB25FQKBW is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQKBW competed?
The extent of competition for SPE2DB25FQKBW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award